Navigation Links
EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program
Date:4/9/2008

Phase 1 study marks the achievement of a critical milestone in our clinical development program and further supports our strategy of focusing on orally-administered, small molecule drugs with multiple mechanisms of action. Data from preclinical studies with ENMD-2076 demonstrate its significant antitumor potential as a single agent in a variety of tumor types. Through this Phase 1 study, we expect to not only determine ENMD-2076's safety profile and appropriate Phase 2 dosing schedule, but which tumor types may be better suited for this compound. We plan to initiate a second Phase 1 study in patients with hematological cancers later this year."

James S. Burns, EntreMed President & Chief Executive Officer commented, "ENMD-2076 is an exciting selective kinase inhibitor with potent single agent activity that has induced tumor regression in multiple preclinical models. ENMD-2076, developed internally, is consistent with our focus on investing behind oncology drug candidates with strong single-agent activity and with our continuing interest in selective kinase inhibitors. In parallel with the clinical trial, we will seek a pharmaceutical or biotech partner to help accelerate the development of our novel selective kinase inhibitor."

The administration of ENMD-2076 to the first patient in this important Phase 1 study will trigger a milestone payment by EntreMed pursuant to EntreMed's acquisition of Miikana Therapeutics, Inc. in January 2006. Under the terms of the merger agreement with Miikana, the dosing of the first patient triggers a $2 million payment to the former Miikana stockholders, either in cash or shares of EntreMed common stock.

About EntreMed

EntreMed, Inc. is a clinical-stage pharmaceutical company developing therapeutic candidates primarily for the treatment of cancer and inflammation. MKC-1 is currently in multiple Phase 2 clinical trials for cancer. MKC-1 is an oral cell-cycle regulator with activity against the mTOR pathway. EN
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. EntreMed Commences Continuous Dosing Clinical Trial For MKC-1
2. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
3. EntreMed to Present at The New York Society of Security Analysts Industry Conference
4. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
5. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
6. EntreMed Reports Phase 1 PK and Preclinical Efficacy Results for ENMD-1198
7. EntreMed Raises $20 Million to Support Clinical Development Program
8. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
9. Bionomics Achieves US$1 Million Milestone Payment from Genmab
10. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
11. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... -- MedicOne Medical Response, a leading provider emergency ... by Inc. Magazine as one of the fastest ... Photo - http://photos.prnewswire.com/prnh/20140914/145997 ... companies with the largest revenue growth between 2010 ... two ambulance companies to make the list, achieved ...
(Date:9/15/2014)...  Catalist-listed QT Vascular Ltd. ("QT Vascular" or together ... of minimally invasive medical devices for the treatment of ... has enrolled the first European patients in the ENDURE ... have already been enrolled in this study with Dr. ... Auckland, New Zealand . ...
(Date:9/15/2014)... , Sept. 15, 2014  Over 200 patients, ... roof Saturday to learn, interact and participate in ... City,s first Lupus Trials Fair launched by the ... S.L.E. Lupus Foundation .  Attendees interacted directly ... -- sharing experiences, ideas and needs and learning ...
Breaking Medicine Technology:MedicOne Medical Response Named to 2014 Inc. 5000 Fastest Growing Companies List 2MedicOne Medical Response Named to 2014 Inc. 5000 Fastest Growing Companies List 3First European Patients Enrolled in QT Vascular's ENDURE Trial 2First European Patients Enrolled in QT Vascular's ENDURE Trial 3First European Patients Enrolled in QT Vascular's ENDURE Trial 4First European Patients Enrolled in QT Vascular's ENDURE Trial 5Lupus Research Institute Launches NYC's First Lupus Trials Fair 2Lupus Research Institute Launches NYC's First Lupus Trials Fair 3
... ROCHESTER, N.Y., Sept. 8 VirtualScopics, Inc. (Nasdaq: ... for clinical trials, announced today that Ms. Molly Henderson, ... presenting a corporate overview at the Rodman & Renshaw ... City. Ms. Henderson,s presentation will be on Tuesday, September ...
... N.J., Sept. 8 Today every major pharmaceutical industry ... the future of pharma.  In an unprecedented move, they,re ... the big names in pharma.  All in one place. ... at the Pharma CI Conference & Exhibition at the ...
Cached Medicine Technology:VirtualScopics to Present at the Upcoming Rodman & Renshaw Annual Global Investment Conference 2Pharmaceutical Industry Insiders, VIPs All Coming Together for Future of Pharma Market, Pharmaceutical Competitive Intelligence 2
(Date:9/15/2014)... (PRWEB) September 15, 2014 Imaging can ... for stroke who might benefit from aggressive intervention, according ... journal Radiology. , The study looked at people ... major blood vessels supplying blood to the head due ... the primary cause of up to 20 percent of ...
(Date:9/15/2014)... OAK BROOK, Ill. Imaging can be a cost-effective ... might benefit from aggressive intervention, according to a new ... . , The study looked at people with ... blood vessels supplying blood to the head due to ... primary cause of up to 20 percent of ischemic ...
(Date:9/15/2014)... San Diego, CA (PRWEB) September 15, 2014 ... has announced its next two-day DISC Certification Workshop ... and HR professionals will meet locally to take part ... be provided with effective tools and activities that can ... certification is designed to teach trainers to educate employees ...
(Date:9/15/2014)... (PRWEB) September 15, 2014 The new ... Monday, Sept. 15 near Raintree Dr. and Loop 101, ... Jim Lane and dignitaries from the healthcare community on ... contains seven operating rooms, four gastro-intestinal procedure rooms, and ... making it the largest surgery center in the state ...
(Date:9/15/2014)... 15, 2014 The Best Hospitals ... Report consists of seven hospitals using OnBase as their ... and Cleveland Clinic were ranked at the top of ... The rankings cover nearly 5,000 medical centers across the ... hospitals that scored highest in at least six of ...
Breaking Medicine News(10 mins):Health News:RSNA: Imaging Identifies Asymptomatic People at Risk for Stroke 2Health News:RSNA: Imaging Identifies Asymptomatic People at Risk for Stroke 3Health News:Imaging identifies asymptomatic people at risk for stroke 2Health News:Imaging identifies asymptomatic people at risk for stroke 3Health News:DISCcert Announces Two-day DISC Certification Workshop Oct 16 and 17 2Health News:DISCcert Announces Two-day DISC Certification Workshop Oct 16 and 17 3Health News:New North Valley Surgery Center Is Arizona’s Largest Outpatient Facility 2Health News:New North Valley Surgery Center Is Arizona’s Largest Outpatient Facility 3Health News:New North Valley Surgery Center Is Arizona’s Largest Outpatient Facility 4Health News:Seven of Top Ten Hospitals in the U.S. Leverage OnBase by Hyland ECM Solution 2
... ... 25 years experience to the workplace resources company , ... Chicago, IL (PRWEB) April 28, 2010 -- ... behavioral healthcare, work/life services, organizational development and wellness services, welcomes Rick Kronberg ...
... to liver failure in some, British researchers say , ... for a mild high is popular in East Africa ... seen among certain immigrant groups in Great Britain and ... severe liver damage and even death, British researchers report. ...
... effective in less than half of cases, study finds , ... identified vitamin E as a treatment that can provide relief ... the most common chronic liver disease. , "This clearly shows ... nonalcoholic steatohepatitis who don,t have active diabetes," said study author ...
... ... retailer of health and fitness products for people who are serious about ... 2010. ,Established in 2000 in Newcastle-upon-Tyne, originally as a mail order company, ... event by launching a new, even more user-friendly website packed with exciting ...
... with a brain arteriovenous malformation (AVM), an abnormal tangle ... of vessel rupture and bleeding that can cause stroke ... preventative interventions, such as endovascular procedures, surgical resection, or ... on the assumption that unruptured AVMs pose similar risk ...
... Md., April 28, 2010 In a major crackdown, ... operating in the country to close within the past ... against Counterfeit & Substandard Medicines (IMC), the shops were ... primary sources of substandard and counterfeit medicines in the ...
Cached Medicine News:Health News:Rick Kronberg Joins Perspectives Ltd As Director of Clinical Services 2Health News:Chewing Khat Linked to Severe Liver Damage 2Health News:Vitamin E Helps Treat Common Liver Disease 2Health News:Vitamin E Helps Treat Common Liver Disease 3Health News:Slimming Solutions Celebrates 10 Years in Business with the Launch of a New Weight Loss Website 2Health News:Do unruptured brain vessel malformations need preventative surgery? 2Health News:Do unruptured brain vessel malformations need preventative surgery? 3Health News:Cambodia takes action in fight against substandard and counterfeit medicines 2Health News:Cambodia takes action in fight against substandard and counterfeit medicines 3
... The Driver Stent design, utilizing ... the limitations of stainless steel ... possible thinner struts, for unparalleled ... The Driver Coronary Stent Systemwith ...
... Guiding Catheter provides support to enhance ... under adverse conditions. It gives you ... to your destination in cardiac interventions. ... variety of clinical situations and the ...
... Catheters are intended for use ... applications. They provide a pathway ... as balloon dilatation catheters, guide ... may be introduced. These devices ...
St. Jude Medical's line of guiding introducers includes Swartz Series, SAFL, SEPT, CSTA, RAMP, and 2 piece steerable...
Medicine Products: